Axsome Therapeutics, Inc. Common Stock (NASDAQ: AXSM) last traded at $207.77, down 0.12% on the session. The quote above updates while this page is open; the figures below are drawn from Axsome Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Axsome Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker AXSM. Its market capitalisation is $10.88 billion.
Valuation measures for Axsome Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $10.88B |
|---|---|
| Enterprise value | $11.24B |
| Price / sales | 14.01 |
| Price / book | 130.64 |
| Beta | 0.59 |
Trailing-twelve-month figures tagged in Axsome Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $776.57M |
|---|---|
| Net income (TTM) | -$191.64M |
| EPS (TTM) | -$3.74 |
| Operating margin | -23.96% |
| Return on equity | -230.05% |
| Cash | $319.85M |
Range and volume for AXSM over the past 52 weeks.
| 52-week high | $260.19 |
|---|---|
| 52-week low | $112.90 |
| Volume | 734.8K |
| Average volume | 870.9K |
| Previous close | $208.03 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.